+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Clinical Trial Supply & Logistics for Pharmaceutical Market - Global Forecast 2026-2032- Product Image
Clinical Trial Supply & Logistics for Pharmaceutical Market - Global Forecast 2026-2032- Product Image
Sale

Clinical Trial Supply & Logistics for Pharmaceutical Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4989664
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Clinical Trial Supply & Logistics for Pharmaceutical Market is projected to reach USD 2.41 Billion in 2026. It is expected to continue growing at a CAGR of 7.81%, reaching USD 3.79 Billion by 2032.

Clinical trial supply and logistics has become a strategic enabler for pharmaceutical, biotechnology, and contract research organizations as trials expand across geographies, therapeutic areas, and patient populations. The function now spans investigational medicinal product planning, comparator sourcing, packaging and labeling, cold chain logistics, depot networks, customs coordination, returns, reconciliation, and destruction.

Market momentum is supported by the globalization of clinical research, the rise of biologics and cell and gene therapies, increased use of decentralized clinical trials, and stricter expectations for temperature control and traceability. Sponsors are prioritizing resilient clinical trial supply chains that protect patient safety, reduce drug waste, maintain Good Distribution Practice compliance, and preserve investigational product integrity across every shipment lane.

Transformative Shifts in the Clinical Supply Landscape

The clinical trial supply landscape is shifting from reactive shipment execution to proactive, data-led supply orchestration. Hybrid and decentralized trial models are increasing demand for direct-to-patient delivery, home healthcare coordination, patient-specific kits, local nursing support, and flexible resupply models supported by validated RTSM and IRT systems.

At the same time, advanced therapies are reshaping cold chain logistics requirements. Biologics, vaccines, and cell and gene therapies often require controlled 2°C to 8°C, frozen, ultra-frozen, or cryogenic handling, making lane qualification, temperature-monitoring devices, validated packaging, and depot readiness essential. Regulatory frameworks such as ICH GCP, EU Clinical Trial Regulation, FDA requirements, and GDP guidance continue to elevate expectations for documentation, quality management, pharmacovigilance alignment, and end-to-end product accountability.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative value across clinical trial supply planning, logistics execution, and quality oversight. AI-enabled forecasting can improve demand planning by analyzing enrollment rates, site activation timelines, patient visit schedules, protocol amendments, dispensing rules, and historical consumption patterns, helping sponsors reduce stockouts, avoid expiry risk, and minimize overproduction.

AI is also improving risk sensing across shipment lanes, depot inventory, customs delays, weather disruption, carrier performance, and temperature excursion probability. When deployed within validated GxP environments, AI can support exception management, document review, predictive maintenance for cold chain assets, and automated alerts. However, industry adoption depends on data integrity, model validation, explainability, cybersecurity, audit trails, and human oversight aligned with 21 CFR Part 11 and global computer system validation expectations.

Key Regional Insights Across Global Trial Logistics

North America remains a leading region for clinical trial supply and logistics due to a high concentration of sponsors, CROs, specialty depots, academic medical centers, and temperature-controlled distribution networks. The United States and Canada benefit from mature regulatory pathways, advanced digital infrastructure, and well-established specialty pharmacy and courier capabilities, while Mexico is gaining importance as a nearshore clinical research and logistics market with growing relevance for regional enrollment and cross-border coordination.

Europe is shaped by the EU Clinical Trial Regulation, CTIS implementation, GDP standards, and strong cross-border trial activity across Germany, France, Italy, Spain, and the United Kingdom, making regulatory documentation, multilingual labeling, qualified person release, and depot coordination critical. Asia-Pacific continues to expand through China, India, Japan, South Korea, Australia, and ASEAN markets, supported by large patient pools, growing biotech investment, regulatory modernization, and improving clinical research infrastructure. Latin America, led by Brazil and Mexico, offers recruitment advantages and strong therapeutic-area diversity but requires robust customs planning, import licensing, local labeling control, and country-specific regulatory expertise. The Middle East, particularly GCC countries, is investing in healthcare infrastructure, specialty hospitals, and clinical research capabilities, while Africa is emerging selectively as sponsors address depot capacity, temperature control, ethics review timelines, import processes, and last-mile logistics resilience.

Key Group Insights for Clinical Trial Supply Networks

The G7 markets represent mature clinical trial supply hubs with established regulators, advanced cold chain capacity, high-quality healthcare systems, and high outsourcing penetration among sponsors and CROs. The European Union adds scale through harmonized clinical trial regulation and CTIS-enabled submission processes, although multilingual labeling, member-state requirements, qualified person release, and cross-border distribution still demand expert coordination.

BRICS countries are increasingly important for patient recruitment, pharmaceutical manufacturing, and regional depot expansion, with China, India, and Brazil standing out for large trial populations, growing domestic innovation, and expanding clinical research infrastructure. ASEAN markets are gaining attention as Singapore, Malaysia, Thailand, Vietnam, Indonesia, and the Philippines improve healthcare research ecosystems, regional connectivity, and temperature-controlled logistics capabilities. The GCC is positioning itself as a premium healthcare and clinical research corridor, supported by hospital investment, regulatory modernization, and logistics infrastructure upgrades. NATO-aligned markets also influence resilience planning, cybersecurity standards, secure transport lanes, sanctions compliance, and contingency routing, which are increasingly relevant for high-value investigational products and advanced therapies.

Key Country Insights for Strategic Trial Execution

The United States is the largest operational anchor for clinical trial supply and logistics, supported by extensive trial activity, FDA oversight, specialty distribution capacity, academic research networks, and advanced cold chain providers. Canada offers high-quality clinical research infrastructure, predictable regulatory processes, and reliable temperature-controlled logistics, while Mexico supports regional diversification, patient access, and nearshore supply strategies. Brazil remains Latin America’s most important clinical research market, combining large patient access with growing demand for reliable importation, labeling, depot services, and customs expertise.

In Europe, the United Kingdom maintains strong early-phase, oncology, vaccine, and specialty trial capabilities, while Germany and France are major pharmaceutical and biotech centers with robust GDP-compliant logistics infrastructure. Italy and Spain are important for oncology, rare disease, and hospital-based studies, supported by experienced investigators and established healthcare networks. Russia presents a more complex operating environment due to geopolitical, sanctions, payment, and logistics constraints, requiring careful feasibility, ethics, import, and compliance assessment before trial execution.

China and India are central to Asia-Pacific growth because of large patient populations, expanding domestic biopharma activity, broader hospital networks, and increasing regulatory modernization. Japan is a high-value market with strict quality expectations, mature clinical operations, and strong demand for compliant labeling and temperature assurance, while Australia is widely used for early-phase studies due to efficient clinical trial pathways, tax incentives, and strong hospital networks. South Korea continues to gain prominence through advanced healthcare infrastructure, oncology expertise, rapid site activation, and globally competitive trial sites.

Actionable Recommendations for Industry Leaders

Industry leaders should build integrated clinical supply operating models that connect protocol design, enrollment forecasting, manufacturing schedules, packaging, labeling, depot planning, RTSM configuration, and logistics execution. Early supply chain involvement in study design can reduce avoidable amendments, excess inventory, resupply delays, and site-level disruptions.

Sponsors and service providers should qualify temperature-controlled lanes, diversify depots and carriers, validate AI-enabled tools, and strengthen real-time visibility across inventory and shipments. Priority actions include robust comparator sourcing governance, direct-to-patient logistics SOPs, cybersecurity controls, sustainability metrics for packaging and transport, vendor risk management, and contingency planning for customs delays, geopolitical disruption, strikes, natural disasters, and temperature excursions.

Research Methodology

The research methodology combines secondary research from regulatory agencies, ICH guidance, WHO resources, GDP frameworks, clinical trial registries, pharmacopeial standards, industry publications, company filings, and logistics standards such as IATA temperature-control guidance. These sources support evidence-based assessment of regulatory expectations, supply chain practices, technology adoption, quality requirements, and regional operating conditions.

Primary validation is conducted through expert interviews and structured discussions with pharmaceutical sponsors, CROs, clinical supply managers, depot operators, specialty logistics providers, packaging vendors, quality leaders, and technology suppliers. Findings are triangulated across service type, trial phase, therapeutic area, temperature range, trial model, end user, and geography to provide a reliable view of clinical trial supply and logistics without relying on unsupported assumptions.

Conclusion

Clinical trial supply and logistics is moving to the center of trial performance, patient access, and regulatory compliance. The market is being reshaped by globalized studies, decentralized models, biologics, cell and gene therapies, stricter cold chain requirements, and increasing demand for real-time visibility across complex supply networks.

Organizations that invest in resilient cold chain logistics, validated digital platforms, AI-supported planning, regional expertise, and patient-centric delivery models will be better positioned to reduce risk and accelerate trial execution. The strongest market participants will combine operational precision with quality governance, sustainability, regulatory readiness, and data-driven decision-making.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Service
7.1. Introduction
7.2. Investigational Drug Packaging
7.3. Drug Labeling Services
7.4. Comparator Drug Sourcing
7.5. Drug Storage & Distribution
7.6. Cold Chain Drug Transportation
7.7. Depot Management
7.8. Returns & Reconciliation
8. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Phase
8.1. Introduction
8.2. Phase I
8.3. Phase II
8.4. Phase III
8.5. Phase IV
9. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Transportation Mode
9.1. Introduction
9.2. Air Freight
9.2.1. Charter
9.2.2. Standard
9.3. Rail Freight
9.3.1. Direct
9.3.2. Intermodal
9.4. Road Freight
9.5. Sea Freight
10. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Temperature Range
10.1. Introduction
10.2. Ambient
10.3. Controlled Room
10.4. Frozen
10.5. Refrigerated
11. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Packaging Type
11.1. Introduction
11.2. Active Packaging
11.2.1. Cryogenic Shippers
11.2.2. Refrigeration Units
11.3. Hybrid Packaging
11.3.1. Combined Solutions
11.3.2. Modular Systems
11.4. Passive Packaging
11.4.1. Insulated Boxes
11.4.2. Thermal Wraps
12. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Molecule Type
12.1. Introduction
12.2. Small Molecule Drugs
12.3. Biopharmaceutical Drugs
13. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Therapeutic Application
13.1. Introduction
13.2. Oncology
13.3. Neurology
13.4. Cardiology
13.5. Infectious Diseases
13.6. Metabolic Disorders
13.7. Respiratory Disorders
14. Clinical Trial Supply & Logistics for Pharmaceutical Market, by End User
14.1. Introduction
14.2. Biotechnology Companies
14.3. Clinical Trial Sites
14.4. Contract Research Organizations
14.5. Pharmaceutical Companies
14.6. Third-Party Logistics Providers
15. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Region
15.1. Asia-Pacific
15.2. Europe
15.3. North America
15.4. Latin America
15.5. Africa
15.6. Middle East
16. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Group
16.1. NATO
16.2. G7
16.3. BRICS
16.4. European Union
16.5. ASEAN
16.6. GCC
17. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Country
17.1. China
17.2. United States
17.3. Japan
17.4. India
17.5. Germany
17.6. United Kingdom
17.7. Australia
17.8. France
17.9. South Korea
17.10. Italy
17.11. Canada
17.12. Russia
17.13. Brazil
17.14. Mexico
17.15. Spain
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. FPNV Positioning Matrix, 2025
18.3. Market Concentration Analysis, 2025
18.3.1. Concentration Ratio (CR)
18.3.2. Herfindahl Hirschman Index (HHI)
18.4. Recent Developments & Impact Analysis, 2025
18.5. Product Portfolio Analysis, 2025
18.6. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Aenova Group GmbH
19.2. Almac Group
19.3. AmerisourceBergen Corporation
19.4. Bilcare Limited
19.5. Biocair International Limited
19.6. Catalent, Inc.
19.7. Clinigen Group PLC
19.8. DHL International GmbH by Deutsche Post AG
19.9. Eurofins Scientific SE
19.10. FedEx Corporation
19.11. GBA Group AG
19.12. ICON PLC
19.13. Infosys Limited
19.14. KLIFO A/S
19.15. Lonza Group
19.16. Metrics Contract Services by Mayne Pharma group
19.17. Movianto
19.18. Nuvisan GmbH
19.19. Parexel International Corporation
19.20. PCI Pharma Services
19.21. Pharm-Olam International Ltd.
19.22. Seveillar Clinical Trial Supplies Pvt. Ltd.
19.23. SIRO Clinpharm Private Limited
19.24. Thermo Fisher Scientific, Inc.
19.25. UDG Healthcare PLC
List of Figures
FIGURE 1. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 25. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 27. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 29. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INVESTIGATIONAL DRUG PACKAGING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INVESTIGATIONAL DRUG PACKAGING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INVESTIGATIONAL DRUG PACKAGING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL DRUG LABELING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL DRUG LABELING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL DRUG LABELING SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL COMPARATOR DRUG SOURCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL COMPARATOR DRUG SOURCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL COMPARATOR DRUG SOURCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL DRUG STORAGE & DISTRIBUTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL DRUG STORAGE & DISTRIBUTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL DRUG STORAGE & DISTRIBUTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL COLD CHAIN DRUG TRANSPORTATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL COLD CHAIN DRUG TRANSPORTATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL COLD CHAIN DRUG TRANSPORTATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL DEPOT MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL DEPOT MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL DEPOT MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL RETURNS & RECONCILIATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL RETURNS & RECONCILIATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL RETURNS & RECONCILIATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL PHASE I MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL PHASE I MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL PHASE I MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL PHASE II MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL PHASE II MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL PHASE II MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL PHASE III MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL PHASE III MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL PHASE III MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL PHASE IV MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL PHASE IV MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL PHASE IV MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL AIR FREIGHT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL AIR FREIGHT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL AIR FREIGHT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CHARTER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CHARTER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CHARTER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL STANDARD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL STANDARD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL STANDARD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL RAIL FREIGHT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL RAIL FREIGHT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL RAIL FREIGHT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL DIRECT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL DIRECT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL DIRECT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL INTERMODAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL INTERMODAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL INTERMODAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL ROAD FREIGHT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ROAD FREIGHT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ROAD FREIGHT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL SEA FREIGHT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL SEA FREIGHT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL SEA FREIGHT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL AMBIENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL AMBIENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL AMBIENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL CONTROLLED ROOM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL CONTROLLED ROOM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL CONTROLLED ROOM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL FROZEN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL FROZEN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL FROZEN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL REFRIGERATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL REFRIGERATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL REFRIGERATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL ACTIVE PACKAGING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL ACTIVE PACKAGING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL ACTIVE PACKAGING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL CRYOGENIC SHIPPERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL CRYOGENIC SHIPPERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL CRYOGENIC SHIPPERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL REFRIGERATION UNITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL REFRIGERATION UNITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL REFRIGERATION UNITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL HYBRID PACKAGING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL HYBRID PACKAGING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL HYBRID PACKAGING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL COMBINED SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL COMBINED SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL COMBINED SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL MODULAR SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL MODULAR SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL MODULAR SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL PASSIVE PACKAGING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL PASSIVE PACKAGING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL PASSIVE PACKAGING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL INSULATED BOXES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL INSULATED BOXES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL INSULATED BOXES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL THERMAL WRAPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL THERMAL WRAPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL THERMAL WRAPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL SMALL MOLECULE DRUGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL SMALL MOLECULE DRUGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL SMALL MOLECULE DRUGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL BIOPHARMACEUTICAL DRUGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL BIOPHARMACEUTICAL DRUGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL BIOPHARMACEUTICAL DRUGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL CLINICAL TRIAL SITES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL CLINICAL TRIAL SITES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL CLINICAL TRIAL SITES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL THIRD-PARTY LOGISTICS PROVIDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL THIRD-PARTY LOGISTICS PROVIDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL THIRD-PARTY LOGISTICS PROVIDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2017-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2017-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2017-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2017-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2017-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2017-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2017-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 161. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 162. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2017-2032 (USD MILLION)
TABLE 163. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2017-2032 (USD MILLION)
TABLE 164. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2017-2032 (USD MILLION)
TABLE 165. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2017-2032 (USD MILLION)
TABLE 166. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2017-2032 (USD MILLION)
TABLE 167. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2017-2032 (USD MILLION)
TABLE 168. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 169. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 170. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2017-2032 (USD MILLION)
TABLE 171. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 172. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 173. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 174. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 175. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 176. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2017-2032 (USD MILLION)
TABLE 177. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2017-2032 (USD MILLION)
TABLE 178. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2017-2032 (USD MILLION)
TABLE 179. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2017-2032 (USD MILLION)
TABLE 180. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2017-2032 (USD MILLION)
TABLE 181. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2017-2032 (USD MILLION)
TABLE 182. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 183. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 184. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2017-2032 (USD MILLION)
TABLE 185. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 186. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 187. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 188. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 189. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 190. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2017-2032 (USD MILLION)
TABLE 191. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2017-2032 (USD MILLION)
TABLE 192. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2017-2032 (USD MILLION)
TABLE 193. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2017-2032 (USD MILLION)
TABLE 194. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2017-2032 (USD MILLION)
TABLE 195. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2017-2032 (USD MILLION)
TABLE 196. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 197. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 198. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2017-2032 (USD MILLION)
TABLE 199. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 200. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 201. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 202. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 203. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 204. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2017-2032 (USD MILLION)
TABLE 205. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2017-2032 (USD MILLION)
TABLE 206. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2017-2032 (USD MILLION)
TABLE 207. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2017-2032 (USD MILLION)
TABLE 208. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2017-2032 (USD MILLION)
TABLE 209. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2017-2032 (USD MILLION)
TABLE 210. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 211. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 212. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2017-2032 (USD MILLION)
TABLE 213. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 214. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 215. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 216. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 217. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 218. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2017-2032 (USD MILLION)
TABLE 219. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2017-2032 (USD MILLION)
TABLE 220. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2017-2032 (USD MILLION)
TABLE 221. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2017-2032 (USD MILLION)
TABLE 222. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2017-2032 (USD MILLION)
TABLE 223. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2017-2032 (USD MILLION)
TABLE 224. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 225. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 226. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2017-2032 (USD MILLION)
TABLE 227. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 228. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 229. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 230. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 231. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 232. NATO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 233. NATO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2017-2032 (USD MILLION)
TABLE 234. NATO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2017-2032 (USD MILLION)
TABLE 235. NATO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2017-2032 (USD MILLION)
TABLE 236. NATO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2017-2032 (USD MILLION)
TABLE 237. NATO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2017-2032 (USD MILLION)
TABLE 238. NATO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2017-2032 (USD MILLION)
TABLE 239. NATO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 240. NATO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 241. NATO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2017-2032 (USD MILLION)
TABLE 242. NATO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 243. NATO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 244. NATO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 245. NATO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 246. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 247. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2017-2032 (USD MILLION)
TABLE 248. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2017-2032 (USD MILLION)
TABLE 249. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2017-2032 (USD MILLION)
TABLE 250. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2017-2032 (USD MILLION)
TABLE 251. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2017-2032 (USD MILLION)
TABLE 252. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2017-2032 (USD MILLION)
TABLE 253. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 254. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 255. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2017-2032 (USD MILLION)
TABLE 256. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 257. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 258. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 259. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 260. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 261. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2017-2032 (USD MILLION)
TABLE 262. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2017-2032 (USD MILLION)
TABLE 263. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2017-2032 (USD MILLION)
TABLE 264. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2017-2032 (USD MILLION)
TABLE 265. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2017-2032 (USD MILLION)
TABLE 266. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2017-2032 (USD MILLION)
TABLE 267. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 268. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 269. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2017-2032 (USD MILLION)
TABLE 270. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 271. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 272. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 273. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2017-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2017-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2017-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2017-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2017-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2017-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 282. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2017-2032 (USD MILLION)
TABLE 284. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 288. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 289. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2017-2032 (USD MILLION)
TABLE 290. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2017-2032 (USD MILLION)
TABLE 291. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2017-2032 (USD MILLION)
TABLE 292. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2017-2032 (USD MILLION)
TABLE 293. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2017-2032 (USD MILLION)
TABLE 294. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2017-2032 (USD MILLION)
TABLE 295. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 296. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 297. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2017-2032 (USD MILLION)
TABLE 298. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2017-2032 (USD MILLION)
TABLE 299. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 300. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 301. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 302. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 303. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2017-2032 (USD MILLION)
TABLE 304. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2017-2032 (USD MILLION)
TABLE 305. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARK

Companies Mentioned

  • Aenova Group GmbH
  • Almac Group
  • AmerisourceBergen Corporation
  • Bilcare Limited
  • Biocair International Limited
  • Catalent, Inc.
  • Clinigen Group PLC
  • DHL International GmbH by Deutsche Post AG
  • Eurofins Scientific SE
  • FedEx Corporation
  • GBA Group AG
  • ICON PLC
  • Infosys Limited
  • KLIFO A/S
  • Lonza Group
  • Metrics Contract Services by Mayne Pharma group
  • Movianto
  • Nuvisan GmbH
  • Parexel International Corporation
  • PCI Pharma Services
  • Pharm-Olam International Ltd.
  • Seveillar Clinical Trial Supplies Pvt. Ltd.
  • SIRO Clinpharm Private Limited
  • Thermo Fisher Scientific, Inc.
  • UDG Healthcare PLC

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.41 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.79 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Clinical Trial Supply & Logistics Market - Global Forecast 2026-2032 - Product Image

Clinical Trial Supply & Logistics Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Clinical Trial Supplies Market - Global Forecast 2026-2032 - Product Image

Clinical Trial Supplies Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Clinical Trial Supply and Logistics - Global Strategic Business Report - Product Image

Clinical Trial Supply and Logistics - Global Strategic Business Report

  • Report
  • 503 Pages
  • Global
From
Clinical Trial Supplies Market Report by Services, Phase, Therapeutic Area, End-Use Industry, and Region 2026-2034 - Product Image

Clinical Trial Supplies Market Report by Services, Phase, Therapeutic Area, End-Use Industry, and Region 2026-2034

  • Report
  • 146 Pages
  • Global
From
Clinical Trial Supplies Market Size, Share & Trends Analysis Report by Phase, Service, Product, Therapeutic Area, Region, and Growth Forecasts, 2026-2033 - Product Image

Clinical Trial Supplies Market Size, Share & Trends Analysis Report by Phase, Service, Product, Therapeutic Area, Region, and Growth Forecasts, 2026-2033

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.